Molecular characterization of muscarinic receptor subtypes in bovine cerebral cortex by radiation inactivation and molecular exclusion h.p.l.c
- PMID: 4052735
- PMCID: PMC1916708
- DOI: 10.1111/j.1476-5381.1985.tb08906.x
Molecular characterization of muscarinic receptor subtypes in bovine cerebral cortex by radiation inactivation and molecular exclusion h.p.l.c
Abstract
Muscarinic receptor subtypes in bovine cerebral cortex were investigated by means of radiation inactivation and molecular exclusion high performance liquid chromatography (h.p.l.c.). The functional molecular size of the muscarinic receptor in situ was determined by the radiation inactivation method. The value for the muscarinic receptor labelled with [3H]-quinuclidinylbenzilate ([3H]-QNB) was 91,000 daltons, while that labelled with [3H]-pirenzepine [( 3H]-PZ) was 157,000 daltons. The muscarinic receptor solubilized with digitonin could be labelled with [3H]-PZ as well as with [3H]-QNB. 3-[(3-Cholamidopropyl)-dimethylammonio] - propane sulphonate (CHAPS) solubilized the muscarinic receptor labelled with [3H]-QNB but not that labelled with [3H]-PZ, in agreement with the low affinity of pirenzepine for inhibiting [3H]-QNB binding in CHAPS-solubilized preparations. The size of the muscarinic receptor in solution was estimated by molecular exclusion h.p.l.c. The digitonin-solubilized muscarinic receptor had a molecular weight of 290,000 and the [3H]-QNB and [3H]-PZ binding activities behaved identically. The CHAPS-solubilized muscarinic receptor labelled with [3H]-QNB was apparently of high molecular weight (greater than 1,000,000 Mr), indicating the formation of aggregates and/or micelles. In the presence of digitonin this form was dissociated into a lower molecular weight species (580,000 Mr). These data indicate that the ligand binding component of the muscarinic receptor species labelled by both [3H]-QNB and [3H]-PZ exists on the same receptor protein, but that the [3H]-PZ binding component in situ is probably coupled to other components in the membrane.
Similar articles
-
Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.J Pharmacol Exp Ther. 1985 Jul;234(1):37-44. J Pharmacol Exp Ther. 1985. PMID: 3839265
-
Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.J Neural Transm. 1988;72(1):11-8. doi: 10.1007/BF01244628. J Neural Transm. 1988. PMID: 3379385
-
Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.Mol Pharmacol. 1988 Sep;34(3):327-33. Mol Pharmacol. 1988. PMID: 3419425
-
Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.J Pharmacol Exp Ther. 1984 Mar;228(3):648-55. J Pharmacol Exp Ther. 1984. PMID: 6546770
-
On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.Acta Pharmacol Toxicol (Copenh). 1986;59 Suppl 1:1-45. Acta Pharmacol Toxicol (Copenh). 1986. PMID: 3524114 Review.
Cited by
-
Interactions between angiotensin II and alpha-adrenoceptor agonists mediating pressor responses in the pithed rat.Br J Pharmacol. 1988 Dec;95(4):1229-40. doi: 10.1111/j.1476-5381.1988.tb11760.x. Br J Pharmacol. 1988. PMID: 2905911 Free PMC article.
-
Oligomerization of G protein-coupled receptors: past, present, and future.Biochemistry. 2004 Dec 21;43(50):15643-56. doi: 10.1021/bi047907k. Biochemistry. 2004. PMID: 15595821 Free PMC article. Review.
-
The effect of ionic strength on cardiac muscarinic receptors.Br J Pharmacol. 1986 Jun;88(2):451-5. doi: 10.1111/j.1476-5381.1986.tb10223.x. Br J Pharmacol. 1986. PMID: 3730701 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources